Cytokine Based Immunotherapy for Cancer and Lymphoma: Biology, Challenges and Future Perspectives

Cytokines regulate both the innate and adaptive immune responses to cancer. Although antitumor activity has been seen for several cytokines in preclinical models, they have had limited success as single therapeutic agents in clinical trials of cancer immunotherapy. However, the possible combinations...

Full description

Bibliographic Details
Main Authors: Suheil Albert Atallah-Yunes, Michael J. Robertson
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-04-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.872010/full
_version_ 1811330407682015232
author Suheil Albert Atallah-Yunes
Michael J. Robertson
author_facet Suheil Albert Atallah-Yunes
Michael J. Robertson
author_sort Suheil Albert Atallah-Yunes
collection DOAJ
description Cytokines regulate both the innate and adaptive immune responses to cancer. Although antitumor activity has been seen for several cytokines in preclinical models, they have had limited success as single therapeutic agents in clinical trials of cancer immunotherapy. However, the possible combinations of cytokines with other immune therapeutics and the advancement in genetic engineering, synthetic biology and cellular and immune therapy has led to the revival of interest in cytokines as anticancer agents. This article will review several immunostimulatory cytokines with anticancer activity, focusing on the those that have been studied in treatment of lymphoma and highlighting recent advances of potential clinical relevance.
first_indexed 2024-04-13T16:00:56Z
format Article
id doaj.art-9665e646d9bd4f418bf2214f7aefdfe5
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-04-13T16:00:56Z
publishDate 2022-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-9665e646d9bd4f418bf2214f7aefdfe52022-12-22T02:40:32ZengFrontiers Media S.A.Frontiers in Immunology1664-32242022-04-011310.3389/fimmu.2022.872010872010Cytokine Based Immunotherapy for Cancer and Lymphoma: Biology, Challenges and Future PerspectivesSuheil Albert Atallah-YunesMichael J. RobertsonCytokines regulate both the innate and adaptive immune responses to cancer. Although antitumor activity has been seen for several cytokines in preclinical models, they have had limited success as single therapeutic agents in clinical trials of cancer immunotherapy. However, the possible combinations of cytokines with other immune therapeutics and the advancement in genetic engineering, synthetic biology and cellular and immune therapy has led to the revival of interest in cytokines as anticancer agents. This article will review several immunostimulatory cytokines with anticancer activity, focusing on the those that have been studied in treatment of lymphoma and highlighting recent advances of potential clinical relevance.https://www.frontiersin.org/articles/10.3389/fimmu.2022.872010/fullcytokinesimmunotherapyinterleukinscancerlymphoma
spellingShingle Suheil Albert Atallah-Yunes
Michael J. Robertson
Cytokine Based Immunotherapy for Cancer and Lymphoma: Biology, Challenges and Future Perspectives
Frontiers in Immunology
cytokines
immunotherapy
interleukins
cancer
lymphoma
title Cytokine Based Immunotherapy for Cancer and Lymphoma: Biology, Challenges and Future Perspectives
title_full Cytokine Based Immunotherapy for Cancer and Lymphoma: Biology, Challenges and Future Perspectives
title_fullStr Cytokine Based Immunotherapy for Cancer and Lymphoma: Biology, Challenges and Future Perspectives
title_full_unstemmed Cytokine Based Immunotherapy for Cancer and Lymphoma: Biology, Challenges and Future Perspectives
title_short Cytokine Based Immunotherapy for Cancer and Lymphoma: Biology, Challenges and Future Perspectives
title_sort cytokine based immunotherapy for cancer and lymphoma biology challenges and future perspectives
topic cytokines
immunotherapy
interleukins
cancer
lymphoma
url https://www.frontiersin.org/articles/10.3389/fimmu.2022.872010/full
work_keys_str_mv AT suheilalbertatallahyunes cytokinebasedimmunotherapyforcancerandlymphomabiologychallengesandfutureperspectives
AT michaeljrobertson cytokinebasedimmunotherapyforcancerandlymphomabiologychallengesandfutureperspectives